Mazzarotto, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 358
AS - Asia 272
EU - Europa 179
AF - Africa 4
OC - Oceania 3
SA - Sud America 2
Totale 818
Nazione #
US - Stati Uniti d'America 353
SG - Singapore 108
HK - Hong Kong 98
TR - Turchia 48
IE - Irlanda 43
RU - Federazione Russa 37
GB - Regno Unito 26
IT - Italia 24
FI - Finlandia 20
DE - Germania 18
CN - Cina 12
CA - Canada 5
IN - India 4
AU - Australia 3
CH - Svizzera 3
SE - Svezia 3
AR - Argentina 1
AT - Austria 1
BE - Belgio 1
BF - Burkina Faso 1
BR - Brasile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
ES - Italia 1
KR - Corea 1
MU - Mauritius 1
NG - Nigeria 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 818
Città #
Hong Kong 98
Singapore 96
Princeton 82
Fairfield 50
Istanbul 45
Dublin 41
San Diego 22
Helsinki 20
Houston 19
Wilmington 19
Seattle 18
Moscow 17
Des Moines 13
Ann Arbor 12
Woodbridge 12
Ashburn 11
Cambridge 10
London 9
Pontassieve 9
San Francisco 8
Brescia 6
Romola 5
Toronto 5
Kilburn 4
Tianjin 4
Chiswick 3
Hanover 3
Melbourne 3
New York 3
Zurich 3
Atlanta 2
Everett 2
Wandsworth 2
Acton 1
Bangkok 1
Beijing 1
Brno 1
Brussels 1
Cascina 1
Chengdu 1
Chuncheon 1
Copenhagen 1
Gunzenhausen 1
Hyderabad 1
Laguna Niguel 1
Oklahoma City 1
Ouagadougou 1
Prescot 1
Pune 1
Redmond 1
Shanghai 1
Southwark 1
Suleja 1
São Paulo 1
Tower Hamlets 1
Vienna 1
Totale 679
Nome #
Genome-wide association testing beyond SNPs 39
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies 28
FineSplice, enhanced splice junction detection and quantification: a novel pipeline based on the assessment of diverse RNA-Seq alignment solutions 28
A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy 25
ZBTB17 (MIZ1) Is Important for the Cardiac Stress Response and a Novel Candidate Gene for Cardiomyopathy and Heart Failure 25
Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients with Hypertrophic Cardiomyopathy 24
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease 24
Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy 23
Comprehensive Assessment of Rare Genetic Variation in Dilated Cardiomyopathy Genes in Patients and Controls (vol 101, pg A41, 2015) 22
Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing? 22
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 22
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 22
Two decades of genetic testing in hypertrophic cardiomyopathy in a single center: The additive value of extended next-generation sequencing panels lies in the early diagnosis of metabolic mimics 21
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 21
Temporal trend in age at diagnosis of hypertrophic cardiomyopathy: an analysis of the share registry 20
INTEGRATED ALLELIC, TRANSCRIPTIONAL, AND PHENOTYPIC DISSECTION OF THE CARDIAC EFFECTS OF TITIN VARIATION IN HEALTH AND DISEASE 20
EFFECTS OF TRUNCATING VARIANTS IN TITIN ON CARDIAC PHENOTYPE AND LEFT VENTRICULAR REMODELLING IN DILATED CARDIOMYOPATHY 19
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples 19
Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy 19
RE-EVALUATING THE GENETIC CONTRIBUTION OF MONOGENIC DILATED CARDIOMYOPATHY 18
Temporal Trend in Age at Diagnosis of Hypertrophic Cardiomyopathy: An Analysis of the Share Registry 18
Quantifying evidence toward pathogenicity for rare phenotypes: the case of succinate dehydrogenase genes, SDHB and SDHD 18
Comparison of long-term clinical course and outcome of MYBPC3-versus MYH7-related hypertrophic cardiomyopathy 17
CLINICAL AND GENETIC CHARACTERISTICS OF FAMILIAL DILATED CARDIOMYOPATHY IN A LARGE UK PROSPECTIVE COHORT 17
Re-evaluating the genetic contribution of monogenic dilated cardiomyopathy 17
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 17
Evidence-Based Assessment of Genes in Dilated Cardiomyopathy 17
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect 17
Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death 17
Titin-truncating variants affect heart function in disease cohorts and the general population 16
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies 16
Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions 16
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 16
Comprehensive sequencing of dilated cardiomyopathy genes reveals additive effects of multiple genes on disease risk and severity 15
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases 15
Genetic ancestry analysis of the Italian founder population carrying the cardiac amyloidosis-causing variant Val122Ile in the transthyretin gene 14
Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation 14
Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy 13
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy 13
Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning 13
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 13
Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death 12
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy 11
A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy 11
Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies 10
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 10
Ion channel dysfunction and fubrosis in atrial fibrillation:Two sides of the same coin 10
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 9
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 8
Totale 871
Categoria #
all - tutte 17.336
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.336


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022330 127 16 2 6 0 18 46 8 13 2 13 79
2022/2023107 41 0 1 4 1 42 2 0 6 9 1 0
2023/2024201 1 2 15 15 5 5 5 4 99 2 0 48
2024/2025233 1 6 6 85 88 47 0 0 0 0 0 0
Totale 871